companydata.dkcompanydata.dk

WI Alpha 9 ApS: Financial statements 2024

CVR: 36938587

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

WI Alpha 9 ApS (CVR 36938587) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -73,000 and a net result of DKK 35,061,000 compared with DKK 35,280,000 the year before. Equity in the 2024 report amounted to DKK 229,655,000. The solvency ratio was 99.6%.

Gross Profit
DKK -73,000
Profit/Loss
DKK 35,061,000
Equity
DKK 229,655,000
Total Assets
DKK 230,488,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--73 t.35.1 mio.229.7 mio.-
2023--66 t.35.3 mio.194.6 mio.-
2022---207.8 mio.159.3 mio.-
2021---594.8 mio.367.2 mio.-
2020--292.3 mio.963 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

WI Alpha 9 ApS: The 2023 annual report is outMar 25, 2024

WI Alpha 9 ApS has published its annual report for 2023. Gross profit came to DKK -66,000, and the net result was DKK 35,280,000.

About WI Alpha 9 ApS

WI Alpha 9 ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Weco Biotech ApS. The management consists of Rasmus Lund-Jacobsen. The company is owned by WECO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -83,000 and a net result of DKK -542,000 compared with DKK 35,061,000 the year before. Equity in the 2025 report amounted to DKK 229,113,000.

Source: annual report 2025, Danish Business Authority